Statin Drugs - Drug Safety Communication: Class Labeling Change
New adverse event and liver enzyme monitoring information in statin labels and updated drug interactions information in lovastatin label.
Undefined
New adverse event and liver enzyme monitoring information in statin labels and updated drug interactions information in lovastatin label.
L’Agenzia Italiana del Farmaco rende disponibile on line nuove ed
importanti informazioni sui medicinali a base di aliskiren in associazione con inibitori dell’enzima di conversione dell’angiotensina (ACE) o bloccanti del recettore dell’angiotensina (ARB).
Women may be left without adequate contraception, and at risk for unintended pregnancy.
Doors and drawers may inadvertently open while bassinet is in motion; product may be difficult to maneuver due to it swivel caster configuration.
Providers should not use the product lots listed for patient care and should immediately quarantine any product for return
Difficulty disconnecting accessories from the tube may result may result in dislodgement of tube and could lead to serious patient injury or death
Affects device and software that aids in the identification and mapping of areas of the brain.
Reports of dosing syringe flow restrictor being pushed into the bottle when inserting the syringe.
Brush head may break off in the user’s mouth or near the face, causing cuts to the mouth and gums, chipped or broken teeth, swallowing and choking on the broken pieces, and injuries to the face and eyes.
Disponibili on line raccomandazioni conclusive relative ai 12 medicinali autorizzati con procedura centralizzata prodotti presso il sito Ben Venue Laboratories.
80.211.154.110